These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30269623)

  • 1. The relationship between health literacy and disease specific costs in subjects with chronic obstructive pulmonary disease (COPD).
    Ture DA; Demirci H; Sengoren Dikis O
    Aging Male; 2020 Dec; 23(5):396-402. PubMed ID: 30269623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health literacy and health outcomes in chronic obstructive pulmonary disease.
    Puente-Maestu L; Calle M; Rodríguez-Hermosa JL; Campuzano A; de Miguel Díez J; Álvarez-Sala JL; Puente-Andues L; Pérez-Gutiérrez MJ; Lee SY
    Respir Med; 2016 Jun; 115():78-82. PubMed ID: 27215508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower health literacy is associated with poorer health status and outcomes in chronic obstructive pulmonary disease.
    Omachi TA; Sarkar U; Yelin EH; Blanc PD; Katz PP
    J Gen Intern Med; 2013 Jan; 28(1):74-81. PubMed ID: 22890622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impacts of a health literacy-informed intervention in people with chronic obstructive pulmonary disease (COPD) on hospitalization, health literacy, self-management, quality of life, and health costs - A randomized controlled trial.
    Borge CR; Larsen MH; Osborne RH; Aas E; Kolle IT; Reinertsen R; Lein MP; Thörn M; Lind RM; Groth M; Strand O; Andersen MH; Moum T; Engebretsen E; Wahl AK
    Patient Educ Couns; 2024 Jun; 123():108220. PubMed ID: 38458089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health Literacy and Health Outcomes in Chronic Obstructive Pulmonary Disease Patients: An Explorative Study.
    Azkan Ture D; Bhattacharya S; Demirci H; Yildiz T
    Front Public Health; 2022; 10():846768. PubMed ID: 35372209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of low health literacy on healthcare utilization in individuals with cardiovascular disease, chronic obstructive pulmonary disease, diabetes and mental disorders. A Danish population-based 4-year follow-up study.
    Friis K; Pedersen MH; Aaby A; Lasgaard M; Maindal HT
    Eur J Public Health; 2020 Oct; 30(5):866-872. PubMed ID: 32335677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. History of Asthma in Patients with Chronic Obstructive Pulmonary Disease. A Comparative Study of Economic Burden.
    Sadatsafavi M; Tavakoli H; Kendzerska T; Gershon A; To T; Aaron SD; FitzGerald JM;
    Ann Am Thorac Soc; 2016 Feb; 13(2):188-96. PubMed ID: 26599154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Health Literacy, Electronic Health Literacy, Disease-Specific Knowledge, and Health-Related Quality of Life Among Adults With Chronic Obstructive Pulmonary Disease: Cross-Sectional Study.
    Stellefson M; Paige SR; Alber JM; Chaney BH; Chaney D; Apperson A; Mohan A
    J Med Internet Res; 2019 Jun; 21(6):e12165. PubMed ID: 31172962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic outcomes among chronic obstructive pulmonary disease Vietnamese patients: Approach considerations from a social perspective.
    Vu TQ; Vo TQ
    J Pak Med Assoc; 2019 Jun; 69(Suppl 2)(6):S64-S74. PubMed ID: 31369536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospitalization Due to Co-Morbid Conditions is the Main Cost Driver Among Subjects With COPD-A Report From the Population-Based OLIN COPD Study.
    Jansson SA; Backman H; Rönmark E; Lundbäck B; Lindberg A
    COPD; 2015 Aug; 12(4):381-9. PubMed ID: 25415366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
    Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
    Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS).
    Singh JA; Yu S
    Respir Res; 2016 Jan; 17():1. PubMed ID: 26739476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors contributing to hospitalization costs for patients with COPD in China: a retrospective analysis of medical record data.
    Li M; Wang F; Chen R; Liang Z; Zhou Y; Yang Y; Chen S; Ung COL; Hu H
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3349-3357. PubMed ID: 30349238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributions of COPD, asthma, and ten comorbid conditions to health care utilization and patient-centered outcomes among US adults with obstructive airway disease.
    Murphy TE; McAvay GJ; Allore HG; Stamm JA; Simonelli PF
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2515-2522. PubMed ID: 28883718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic burden of chronic obstructive pulmonary disease.
    Teo WS; Tan WS; Chong WF; Abisheganaden J; Lew YJ; Lim TK; Heng BH
    Respirology; 2012 Jan; 17(1):120-6. PubMed ID: 21954985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-care utilization and expenditures among patients with comorbid bronchiectasis and chronic obstructive pulmonary disease in US clinical practice.
    Seifer FD; Hansen G; Weycker D
    Chron Respir Dis; 2019; 16():1479973119839961. PubMed ID: 30961354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.
    Schwab P; Dhamane AD; Hopson SD; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():735-744. PubMed ID: 28260880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.